Fineline Cube

Follow:
14435 Articles
CompanyDrug

Junshi Biosciences’ Neotorch Study Achieves Superiority in Lung Cancer Trial

CompanyDrug

Hengrui’s EZH2 Inhibitor SHR2554 Nears Breakthrough Therapy Designation

CompanyDeals

Henlius Terminates TROP2 Antibody Licensing Deal with Chiome Bioscience

CompanyDeals

Structure Therapeutics Files for IPO on NASDAQ to Raise $119M

CompanyDrug

Hansoh’s HS-10517 Greenlit for COVID-19 Clinical Study by NMPA

CompanyDeals

Cowell Health Partners with Gilead Sciences to Enhance Drug Accessibility

CompanyDeals

IASO Bio Raises RMB 500 Million in Series C1 Funding for Cell Therapy Pipeline

CompanyDrug

Junshi Biosciences’ COVID-19 Drug JT001 (VV116) Accepted for NMPA Review

CompanyDrug

Bristol-Myers Squibb’s Opdivo Gains New Indication for NSCLC Neoadjuvant Therapy in China

CompanyDrug

Daiichi Sankyo’s Mirogabalin Nears China Market Entry with CDE Review

CompanyDrug

Bio-Thera’s Biosimilar BAT1806 Passes NMPA Review, Targets Roche’s Actemra

CompanyDrug

Abbisko’s ABSK021 Gains NMPA Approval for Phase II Study in cGVHD